Triazole-substituted N-hydroxyindol-2-carboxylates as inhibitors of isoform 5 of human lactate dehydrogenase (hLDH5)

Carlotta Granchi, Sarabindu Roy, Claudia Del Fiandra, Tiziano Tuccinardi, Mario Lanza, Laura Betti, Gino Giannaccini, Antonio Lucacchini, Adriano Martinelli, Marco MacChia, Filippo Minutolo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

hLDH5 plays a key role in the glycolytic metabolic switch found in invasive tumours and is now considered as a promising therapeutic target in cancer. Here we report a series of new hLDH5-inhibitors based on triazole-containing N-hydroxyindol-2-carboxylates, whose synthesis includes the highly reliable and simple "click chemistry" reaction.

Original languageEnglish (US)
Pages (from-to)638-643
Number of pages6
JournalMedChemComm
Volume2
Issue number7
DOIs
StatePublished - Jul 2011

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Triazole-substituted N-hydroxyindol-2-carboxylates as inhibitors of isoform 5 of human lactate dehydrogenase (hLDH5)'. Together they form a unique fingerprint.

Cite this